About: Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trial     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 09 April 2012

AttributesValues
rdf:type
description
  • article científic (ca)
  • article scientific (oc)
  • articol științific (ro)
  • articolo scientifico (it)
  • artigo científico (gl)
  • artikull shkencor (sq)
  • artikulong pang-agham (tl)
  • artykuł naukowy (pl)
  • bilimsel makale (tr)
  • mokslinis straipsnis (lt)
  • scienca artikolo (eo)
  • teaduslik artikkel (et)
  • tieteellinen artikkeli (fi)
  • tudományos cikk (hu)
  • vedecký článok (sk)
  • vetenskaplig artikel (sv)
  • vitenskapelig artikkel (nb)
  • vitskapeleg artikkel (nn)
  • vědecký článek (cs)
  • wetenschappelijk artikel (nl)
  • wissenschaftlicher Artikel (de)
  • επιστημονικό άρθρο (el)
  • мақолаи илмӣ (tg)
  • научна статия (bg)
  • научная статья (ru)
  • научни чланак (sr)
  • מאמר מדעי (he)
  • სამეცნიერო სტატია (ka)
  • บทความทางวิทยาศาสตร์ (th)
  • artikel ilmiah (id)
  • bài báo khoa học (vi)
  • naučni članak (sr-el)
  • мақолаи илмӣ (tg-cyrl)
  • научни чланак (sr-ec)
  • سائنسی مضمون (ur)
  • مقالهٔ علمی (fa)
  • artículu científicu espublizáu en 2012 (ast)
  • article scientifique publié en 2012 (fr)
  • наукова стаття, опублікована у квітні 2012 (uk)
  • ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ (bn)
  • 2012 nî lūn-bûn (nan)
  • 2012年の論文 (ja)
  • 2012년 논문 (ko)
  • artigo científico (publicado na 2012) (pt)
  • artigo científico (publicado na 2012) (pt-br)
  • artículo científico publicado en 2012 (es)
  • 2012年学术文章 (zh-cn)
  • 2012年学术文章 (zh-sg)
  • 2012年学术文章 (zh-hans)
  • 2012年学术文章 (wuu)
  • 2012年学术文章 (zh-my)
  • 2012年學術文章 (zh)
  • 2012年學術文章 (zh-hk)
  • 2012年學術文章 (zh-tw)
  • 2012年學術文章 (zh-hant)
  • 2012年學術文章 (yue)
  • 2012年學術文章 (zh-mo)
  • videnskabelig artikel (udgivet 2012) (da)
  • مقالة علمية نشرت في 09 أبريل 2012 (ar)
  • scientific article published on 09 April 2012 (en)
  • scientific article published on 09 April 2012 (en-ca)
  • scientific article published on 09 April 2012 (en-gb)
  • գիտական հոդված հրատարակված 2012 թվականի ապրիլի 9-ին (hy)
publication date
publication date
language of work or name
language of work or name
author name string
author name string
  • Richard Jackson
  • Anton Kruger
  • Adrian Bloor
  • Anna Schuh
  • Samir Agrawal
  • Julie Blundell
  • Susanna Dodd
  • James Dodd
  • Gillian G Johnson
  • Stacey Carruthers
  • Stephen Proctor
  • Earnest Heartin
rdfs:label
  • Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trial (en)
  • Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trial (nl)
  • Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trial (en-gb)
  • Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trial (ast)
skos:prefLabel
  • Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trial (en)
  • Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trial (nl)
  • Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trial (en-gb)
  • Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trial (ast)
Faceted Search & Find service v1.16.117 as of May 05 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software